CIPDB › China Industry › Chemicals › Pharmaceutical Intermediate
Xyx Factory Retatrutide Lyophilized Powder for Sale Reta 2381089-83-2 and Weight Loss1
Pharmaceutical IntermediateRetatrutide2381089-83-2
Nanjing Xiyuxun Technology Co., Ltd
Preview:
Product Description Retatrutide PropertiesRetatrutide PropertiesStorage temp.-20°CFormpowderAppearance White lyophilizedWater SolubilitySoluble in water (5mg/ml).Functionweight loss Retatrutide Chemical Properties,Uses,ProductionDescriptionRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent in-sulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent in-sulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating in-sulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes. Biological ActivityRetatrutide (LY3437943), a single peptide conjugated to a lipid diacid molecule, exerts a powerful agonist effect on the human glucagon‐receptor (GCGR), GIPR, and GLP‐1R. In comparison with the human glucagon and glucagon‐like peptide 1 (GLP‐1), retatrutide exhibits reduced potency (by a factor of 0.3 and 0.4, respectively) on the GCGR and GLP‐1R while displaying enhanced potency at the human GIPR (by a factor of 8.9) when compared to the glucose‐dependent in-sulinotropic polypeptide (GIP)[7]. Mechanism of actionWhen injected into mice suffering from diabetes-induced kidney injury, retatrutide was found to markedly reduce albuminuria levels while also increasing renal filtration rate. This was attributed to its ability to activate GLP-1R/GR-dependent signalling pathways, which then produced anti-inflammatory and antiapoptotic effects that protected the kidneys from further damage. Additionally, it has been shown to directly modulate glomerular permeability, thus leading to improved urinary concentration. Initial results indicate that the peptide can induce marked improvements in albuminuria levels within just four weeks of treatment when compared to other treatments for chronic kidney disease such as ACE inhibitors or angiotensin receptor blockers (ARBs). Moreover, retatrutide has demonstrated a greater effect than either ACE inhibitors or ARBs at reducing systolic blood pressure without inducing significant side effects. Side effectsThe most common side effects of retatrutide are gastrointestinal, including: Nausea, Diarrhea, Vomiting, and Constipation. At higher doses, researchers stated these symptoms were "mostly mild to moderate in severity" and typically treated by lowering the dosage. However, 7% of patients also experienced skin tingling. At 24 weeks of treatment, patients' heart rates on higher doses peaked but declined afterward.Main Marketing : North America, South America, Eastern EuropeWho are we?:Nanjing XYX Technology Co.,Ltd is mainly engaged in the export of fine chemicals, cosmetic raw materials, food additives, pharmaceutical intermediates and other products; Our company is committed to the development of international market , our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc. Meanwhile, we possess of complete Q.A. and Q.C. system, supply chemical products with good quality and customerized products due to our clients' requirement. Our professional sales team focuses on quality and after service, and our team leader has been on excellent experience and perfect performance over the 10 years. With our constant efforts and good service, We expect to establish long-term cooperation and common development with our customers sincerely .THE KEY : WORK WITH US PRODUCT DEVELOPMENT : Portflio management Identification and justification of development candidates Marketing research Project management Patent research and evaluation Coordination of development activities Business development Our Sourcing : Marketing &sales : Qualification of API-manufacturers Global marketing and sales GMP-Consulting Storage in our own GMP-compliant warehouse Audits Well control supply chain Customer preparation of inspections Just-in-time supply Support during inspections Representative offices worldwide Compilation and registration of DMF'SRFQQ: How to start orders or make payments?A:You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.Q: How to confirm the Product Quality before placing orders?A:You can get samples for some products to test. You can send us your product specifications and requests,we will manufacture the products according to your requests.Q: What's your MOQ?A:For the high value product, our MOQ starts from 1box.Q: Is there a discount?A: Yes, for larger quantity, we always support with better price.Q:How do you treat quality complaint?First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.Q:How to contact us ?You can choose your interested products and send inquiry to us.You can dial our telephone directly.
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...
Message:
OK ! We suggest you detail your product requirements and company information here.
Enter between 20 to 4,000 characters.
Your inquiry content must be between 20 to 4000 characters.